Use Central Contact
Rare Disease / Clinical Research
Astellas Pharma Inc
PI on 31 trials
ℹ
Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.
Report missing dataRare diseases treated or studied
Based on trial PI assignments and publication topics.
- Invasive candidiasis
- Familial Mediterranean fever
- Multiple endocrine neoplasia type 1
- Acute lymphoblastic leukemia
- Systemic lupus erythematosus
- CEBPE-associated autoinflammation-immunodeficiency-neutrophil dysfunction syndrome
- Glycogen storage disease due to acid maltase deficiency
- Cap myopathy
- Cat-eye syndrome
- Aspergillosis
- Autoimmune polyendocrinopathy
- Triple A syndrome
- Catastrophic antiphospholipid syndrome
- Macrophagic myofasciitis
- Wiskott-Aldrich syndrome
- Agranulocytosis
- Complication in hemodialysis
- Body integrity dysphoria
- Systemic autoimmune disease
Clinical trials (31)
Verify independently
Other specialists for Invasive candidiasis
Peers ranked by clinical-trial PI role, publications, and verification quality.
- Robert Krause, MDMedical University of Graz
- Laura Cox, PhDMundipharma Research Limited
- Shan-Chwen Chang, MDNational Taiwan University Hospital
- Hana Slepčanová, Mgr.University Hospital Ostrava
- Luigi PicaroGilead Sciences
- MJP van Wanrooy, PharmDUniversity Medical Center Groningen
- Taylor Sandison, MD MPHCidara TherapeuticsWA
- Jean-Francois TIMSIT, ProfessorAssistance Publique - Hôpitaux de Paris